Anti-Human CCR2 Therapeutic Antibody (Plozalizumab)
Recombinant monoclonal antibody to CCR2. Plozalizumab is a humanized monoclonal antibody that can be potentially used in the treatment of Atherosclerosis, Diabetic nephropathies, Malignant melanoma. It binds to CCR2 and prevents binding of the endothelium-derived CLL2 (monocyte chemoattractant protein-1 or MCP1) to its receptor CCR2.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-444CQ |
| Pricing | Inquiry |
| Host | Human |
| Target | CCR2 |
| Species Reactivity | Human |
| Type | IgG1, κ |
| Applications | Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Inhibition |
| Storage | Store at -20°C for long-term storage. Avoid freeze/thaw cycles. |